KRATOS DEFENSE & SECURITY SOLUTIONS, INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that KRATOS DEFENSE & SECURITY SOLUTIONS, INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $751.90M | Feb 28, 2018 |
| FY2017 | Dec 25, 2016 | $668.70M | Feb 28, 2018 |
| FY2017 | Dec 27, 2015 | $657.10M | Feb 28, 2018 |
| FY2016 | Dec 28, 2014 | $763.00M | Feb 27, 2017 |
| FY2015 | Dec 29, 2013 | $844.10M | Mar 11, 2016 |
| FY2014 | Dec 30, 2012 | $969.20M | Mar 13, 2015 |
| FY2013 | Dec 25, 2011 | $54.30M | Mar 12, 2014 |
| FY2011 | Dec 26, 2010 | $408.50M | Dec 7, 2012 |
| FY2011 | Dec 27, 2009 | $334.50M | Dec 7, 2012 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 28, 2025 | $1.35B | Feb 23, 2026 |
| FY2025 | Dec 29, 2024 | $1.14B | Feb 23, 2026 |
| FY2025 | Dec 31, 2023 | $1.04B | Feb 23, 2026 |
| FY2024 | Dec 25, 2022 | $898.30M | Feb 26, 2025 |
| FY2023 | Dec 26, 2021 | $811.50M | Feb 13, 2024 |
| FY2020 | Dec 27, 2020 | $206.40M | Feb 25, 2021 |
| FY2020 | Sep 27, 2020 | $202.00M | Feb 25, 2021 |
| FY2020 | Jun 28, 2020 | $170.40M | Feb 25, 2021 |
| FY2020 | Mar 29, 2020 | $168.90M | Feb 25, 2021 |
| FY2020 | Dec 29, 2019 | $185.10M | Feb 25, 2021 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $202.20M | Feb 28, 2018 |
| FY2017 | Oct 1, 2017 | $196.20M | Feb 28, 2018 |
| FY2017 | Jun 25, 2017 | $185.70M | Feb 28, 2018 |
| FY2017 | Mar 26, 2017 | $167.80M | Feb 28, 2018 |
| FY2017 | Dec 25, 2016 | $182.10M | Feb 28, 2018 |
| FY2017 | Sep 25, 2016 | $165.40M | Feb 28, 2018 |
| FY2017 | Jun 26, 2016 | $168.20M | Feb 28, 2018 |
| FY2017 | Mar 27, 2016 | $153.00M | Feb 28, 2018 |
| FY2016 | Dec 27, 2015 | $177.50M | Feb 27, 2017 |
| FY2016 | Sep 27, 2015 | $161.70M | Feb 27, 2017 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 28, 2025 | $307.90M | Feb 23, 2026 |
| FY2025 | Dec 29, 2024 | $287.20M | Feb 23, 2026 |
| FY2025 | Dec 31, 2023 | $268.60M | Feb 23, 2026 |
| FY2024 | Dec 25, 2022 | $226.00M | Feb 26, 2025 |
| FY2023 | Dec 26, 2021 | $225.10M | Feb 13, 2024 |
| FY2020 | Dec 27, 2020 | $54.30M | Feb 25, 2021 |
| FY2020 | Sep 27, 2020 | $57.10M | Feb 25, 2021 |
| FY2020 | Jun 28, 2020 | $46.00M | Feb 25, 2021 |
| FY2020 | Mar 29, 2020 | $45.80M | Feb 25, 2021 |
| FY2020 | Dec 29, 2019 | $48.40M | Feb 25, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 28, 2025 | $22.00M | Feb 23, 2026 |
| FY2025 | Dec 29, 2024 | $16.30M | Feb 23, 2026 |
| FY2025 | Dec 31, 2023 | ($8.90M) | Feb 23, 2026 |
| FY2024 | Dec 25, 2022 | ($36.90M) | Feb 26, 2025 |
| FY2023 | Dec 26, 2021 | ($2.00M) | Feb 13, 2024 |
| FY2020 | Dec 27, 2020 | $78.10M | Feb 25, 2021 |
| FY2020 | Sep 27, 2020 | $2.40M | Feb 25, 2021 |
| FY2020 | Jun 28, 2020 | ($700.0K) | Feb 25, 2021 |
| FY2020 | Mar 29, 2020 | ($200.0K) | Feb 25, 2021 |
| FY2020 | Dec 29, 2019 | $3.00M | Feb 25, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 28, 2025 | $25.60M | Feb 23, 2026 |
| FY2025 | Dec 29, 2024 | $29.00M | Feb 23, 2026 |
| FY2025 | Dec 31, 2023 | $31.10M | Feb 23, 2026 |
| FY2024 | Dec 25, 2022 | ($2.90M) | Feb 26, 2025 |
| FY2023 | Dec 26, 2021 | $27.90M | Feb 13, 2024 |
| FY2020 | Dec 27, 2020 | $9.00M | Feb 25, 2021 |
| FY2020 | Sep 27, 2020 | $12.70M | Feb 25, 2021 |
| FY2020 | Jun 28, 2020 | $2.90M | Feb 25, 2021 |
| FY2020 | Mar 29, 2020 | $4.70M | Feb 25, 2021 |
| FY2020 | Dec 29, 2019 | $9.30M | Feb 25, 2021 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 28, 2025 | $40.00M | Feb 23, 2026 |
| FY2025 | Dec 29, 2024 | $40.30M | Feb 23, 2026 |
| FY2025 | Dec 31, 2023 | $38.40M | Feb 23, 2026 |
| FY2024 | Dec 25, 2022 | $38.60M | Feb 26, 2025 |
| FY2023 | Dec 26, 2021 | $35.20M | Feb 13, 2024 |
| FY2022 | Dec 27, 2020 | $27.00M | Feb 23, 2023 |
| FY2021 | Dec 29, 2019 | $18.00M | Feb 22, 2022 |
| FY2020 | Dec 30, 2018 | $15.60M | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $17.80M | Feb 24, 2020 |
| FY2018 | Dec 25, 2016 | $13.90M | Feb 28, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 28, 2025 | $240.20M | Feb 23, 2026 |
| FY2025 | Dec 29, 2024 | $217.20M | Feb 23, 2026 |
| FY2025 | Dec 31, 2023 | $198.70M | Feb 23, 2026 |
| FY2024 | Dec 25, 2022 | $182.80M | Feb 26, 2025 |
| FY2023 | Dec 26, 2021 | $160.20M | Feb 13, 2024 |
| FY2022 | Dec 27, 2020 | $144.50M | Feb 23, 2023 |
| FY2021 | Dec 29, 2019 | $130.80M | Feb 22, 2022 |
| FY2020 | Dec 30, 2018 | $119.80M | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $127.30M | Feb 24, 2020 |
| FY2018 | Dec 25, 2016 | $114.60M | Feb 28, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 28, 2025 | ($42.10M) | Feb 23, 2026 |
| FY2025 | Dec 29, 2024 | $49.70M | Feb 23, 2026 |
| FY2025 | Dec 31, 2023 | $65.20M | Feb 23, 2026 |
| FY2024 | Dec 25, 2022 | ($25.70M) | Feb 26, 2025 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 28, 2025 | $2.47B | Feb 23, 2026 |
| FY2025 | Dec 29, 2024 | $1.95B | Feb 23, 2026 |
| FY2024 | Dec 31, 2023 | $1.63B | Feb 26, 2025 |
| FY2023 | Dec 25, 2022 | $1.55B | Feb 13, 2024 |
| FY2023 | Dec 26, 2021 | $1.59B | Feb 13, 2024 |
| FY2022 | Dec 27, 2020 | $1.56B | Feb 23, 2023 |
| FY2021 | Dec 29, 2019 | $1.19B | Feb 22, 2022 |
| FY2020 | Dec 30, 2018 | $1.01B | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $1.02B | Feb 24, 2020 |
| FY2018 | Dec 25, 2016 | $948.60M | Feb 28, 2019 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 28, 2025 | $470.90M | Feb 23, 2026 |
| FY2025 | Dec 29, 2024 | $597.70M | Feb 23, 2026 |
| FY2024 | Dec 31, 2023 | $634.00M | Feb 26, 2025 |
| FY2023 | Dec 25, 2022 | $604.00M | Feb 13, 2024 |
| FY2022 | Dec 26, 2021 | $629.20M | Feb 23, 2023 |
| FY2021 | Dec 27, 2020 | $622.70M | Feb 22, 2022 |
| FY2020 | Dec 29, 2019 | $596.90M | Feb 25, 2021 |
| FY2019 | Dec 30, 2018 | $490.80M | Feb 24, 2020 |
| FY2018 | Dec 31, 2017 | $512.50M | Feb 28, 2019 |
| FY2017 | Dec 25, 2016 | $672.20M | Feb 28, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 28, 2025 | $2.00B | Feb 23, 2026 |
| FY2025 | Dec 29, 2024 | $1.35B | Feb 23, 2026 |
| FY2011 | Dec 25, 2011 | $312.60M | Dec 7, 2012 |
| FY2011 | Dec 26, 2010 | $169.90M | Dec 7, 2012 |
| FY2011 | Dec 27, 2009 | $124.90M | Dec 7, 2012 |
| FY2011 | Dec 28, 2008 | $146.90M | Dec 7, 2012 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 28, 2025 | $595.70M | Feb 23, 2026 |
| FY2025 | Dec 29, 2024 | $568.90M | Feb 23, 2026 |
| FY2024 | Dec 31, 2023 | $569.10M | Feb 26, 2025 |
| FY2023 | Dec 25, 2022 | $558.20M | Feb 13, 2024 |
| FY2022 | Dec 26, 2021 | $493.90M | Feb 23, 2023 |
| FY2021 | Dec 27, 2020 | $483.90M | Feb 22, 2022 |
| FY2020 | Dec 29, 2019 | $455.60M | Feb 25, 2021 |
| FY2019 | Dec 30, 2018 | $425.70M | Feb 24, 2020 |
| FY2018 | Dec 31, 2017 | $425.70M | Feb 28, 2019 |
| FY2017 | Dec 25, 2016 | $485.40M | Feb 28, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 28, 2025 | ($641.90M) | Feb 23, 2026 |
| FY2025 | Dec 29, 2024 | ($663.90M) | Feb 23, 2026 |
| FY2024 | Dec 31, 2023 | ($680.20M) | Feb 26, 2025 |
| FY2023 | Dec 25, 2022 | ($671.30M) | Feb 13, 2024 |
| FY2022 | Dec 26, 2021 | ($634.40M) | Feb 23, 2023 |
| FY2021 | Dec 27, 2020 | ($632.40M) | Feb 22, 2022 |
| FY2020 | Dec 29, 2019 | ($712.00M) | Feb 25, 2021 |
| FY2019 | Dec 30, 2018 | ($724.50M) | Feb 24, 2020 |
| FY2018 | Dec 31, 2017 | ($720.80M) | Feb 28, 2019 |
| FY2017 | Dec 25, 2016 | ($678.10M) | Feb 28, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 28, 2025 | $560.60M | Feb 23, 2026 |
| FY2025 | Dec 29, 2024 | $329.30M | Feb 23, 2026 |
| FY2024 | Dec 31, 2023 | $72.80M | Feb 26, 2025 |
| FY2023 | Dec 25, 2022 | $81.30M | Feb 13, 2024 |
| FY2022 | Dec 26, 2021 | $349.40M | Feb 23, 2023 |
| FY2021 | Dec 27, 2020 | $380.80M | Feb 22, 2022 |
| FY2020 | Dec 29, 2019 | $172.60M | Feb 25, 2021 |
| FY2019 | Dec 30, 2018 | $182.70M | Feb 24, 2020 |
| FY2018 | Dec 31, 2017 | $130.50M | Feb 28, 2019 |
| FY2017 | Dec 25, 2016 | $69.10M | Feb 28, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 26, 2021 | $296.70M | Feb 23, 2023 |
| FY2021 | Dec 27, 2020 | $301.50M | Feb 22, 2022 |
| FY2020 | Dec 29, 2019 | $295.10M | Feb 25, 2021 |
| FY2019 | Dec 30, 2018 | $294.20M | Feb 24, 2020 |
| FY2018 | Dec 31, 2017 | $294.30M | Feb 28, 2019 |
| FY2017 | Dec 25, 2016 | $432.00M | Feb 28, 2018 |
| FY2016 | Dec 27, 2015 | $445.10M | Feb 27, 2017 |
| FY2015 | Dec 28, 2014 | $656.40M | Mar 11, 2016 |
| FY2014 | Dec 29, 2013 | $644.30M | Mar 13, 2015 |
| FY2013 | Dec 30, 2012 | $649.40M | Mar 12, 2014 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 28, 2025 | 0 | Feb 23, 2026 |
| FY2025 | Dec 29, 2024 | 0 | Feb 23, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 23, 2026 |
| FY2024 | Dec 25, 2022 | 0 | Feb 26, 2025 |
| FY2023 | Dec 26, 2021 | 0 | Feb 13, 2024 |
| FY2020 | Dec 27, 2020 | 0 | Feb 25, 2021 |
| FY2020 | Sep 27, 2020 | 0 | Feb 25, 2021 |
| FY2020 | Jun 28, 2020 | 0 | Feb 25, 2021 |
| FY2020 | Mar 29, 2020 | 0 | Feb 25, 2021 |
| FY2020 | Dec 29, 2019 | 0 | Feb 25, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 28, 2025 | 0 | Feb 23, 2026 |
| FY2025 | Dec 29, 2024 | 0 | Feb 23, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 23, 2026 |
| FY2024 | Dec 25, 2022 | 0 | Feb 26, 2025 |
| FY2023 | Dec 26, 2021 | 0 | Feb 13, 2024 |
| FY2020 | Dec 27, 2020 | 0 | Feb 25, 2021 |
| FY2020 | Sep 27, 2020 | 0 | Feb 25, 2021 |
| FY2020 | Jun 28, 2020 | 0 | Feb 25, 2021 |
| FY2020 | Mar 29, 2020 | 0 | Feb 25, 2021 |
| FY2020 | Dec 29, 2019 | 0 | Feb 25, 2021 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 28, 2025 | 168.88M | Feb 23, 2026 |
| FY2025 | Dec 29, 2024 | 151.09M | Feb 23, 2026 |
| FY2024 | Dec 31, 2023 | 129.29M | Feb 26, 2025 |
| FY2023 | Dec 25, 2022 | 125.99M | Feb 13, 2024 |
| FY2022 | Dec 26, 2021 | 123.99M | Feb 23, 2023 |
| FY2021 | Dec 27, 2020 | 123.05M | Feb 22, 2022 |
| FY2020 | Dec 29, 2019 | 106.64M | Feb 25, 2021 |
| FY2019 | Dec 30, 2018 | 103.77M | Feb 24, 2020 |
| FY2018 | Dec 31, 2017 | 103.30M | Feb 28, 2019 |
| FY2017 | Dec 25, 2016 | 73.95M | Feb 28, 2018 |